Table 2 Unadjusted and adjusted proportional hazards regression evaluating factors associated with loss to follow-up among HIV-infected patients with Kaposi’s sarcoma from Kenya, Uganda, Nigeria, Cameroon and Malawi

  ≥ 40

Reference

Reference

 35–39

1.00 (0.78–1.29)

0.96

1.06 (0.82–1.36)

0.69

 30–34

1.01 (0.80–1.28)

0.93

1.09 (0.85–1.38)

0.50

  < 30

1.30 (1.03–1.64)

0.03

1.41 (1.11–1.79)

0.005

 Female

Reference

Reference

 Male

1.08 (0.91–1.30)

0.38

1.35 (1.12–1.63)

0.002

  > 350

Reference

Reference

 201–350

1.00 (0.74–1.35)

0.99

1.03 (0.75–1.42)

0.84

 51–200

1.10 (0.82–1.49)

0.52

1.14 (0.84–1.54)

0.24

  ≤ 50

1.25 (0.92–1.68)

0.15

1.23 (0.90–1.67)

0.19